| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/28/2008 | CN101185655A Medicinal composition for treating diabetes chronic complication and preparation method thereof |
| 05/28/2008 | CN101185648A Pharmaceutical composition with memantine hydrochloride and huperzine A as active components and preparation method and use thereof |
| 05/28/2008 | CN101185644A Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia |
| 05/28/2008 | CN101185471A Tea capable of giving up smoking and preparation method thereof |
| 05/28/2008 | CN100390296C Novel primers for screening schizop hrenia and method thereof |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390174C Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 05/28/2008 | CN100390173C Tricyclic compound |
| 05/28/2008 | CN100390168C 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and their use as anti-depressants |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390157C Substituted benzoxazinones and uses thereof |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CN100389813C Composite preparation for resisting oxidation, preventing and treating senile dementia and preparation method thereof |
| 05/28/2008 | CN100389812C Medicine for stopping smoking |
| 05/28/2008 | CN100389811C Wind dispelling drop pill containing amomum fruit |
| 05/28/2008 | CN100389788C Extract of perilla and its use in preparation of medicine |
| 05/28/2008 | CN100389783C Extraction process of effective Chuanxiong component |
| 05/28/2008 | CN100389780C Traditional Chinese medicine for treating depressive disorders, and its prepn. method |
| 05/28/2008 | CN100389777C Moderate molecular weighted chondroitin sulfate injection and its preparing process |
| 05/28/2008 | CN100389751C Swallow tablet comprising paracetamol |
| 05/28/2008 | CN100389685C Alcohol free spirit |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378519 enantiomerically pure 1S,2S-tramadol hydrochloride by dissolving topiramate and tramadol hydrochloride; cooling; crystallization; filtration; separating the 1S,2S-tramadol hydrochloride from the mother liquor by chromatography or crystallization |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/27/2008 | US7378492 CD40-related receptor that binds CD40L |
| 05/27/2008 | US7378447 Muscarinic agonists |
| 05/27/2008 | US7378436 Substituted N-[pyrrolidin-3-yl] benzamides or naphthamides; serotonin and noradrenaline receptor antagonists; urinary incontinence; arylation of the amino pyrrolidine with a carboxylic acid or acyl halide and then deprotecting |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378425 For preventing, treating and/or improving a disease against which a sigma receptor binding action and/or an acetylcholinesterase inhibitory action is efficacious |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378389 Neurotoxic component has been purified from a botulinum toxin by fermenting a Clostridium botulinum to botulinum toxin type A; promotion of normal muscle growth |
| 05/27/2008 | US7378111 Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2379752C Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients |
| 05/27/2008 | CA2345064C Fentanyl composition for the treatment of acute pain |
| 05/22/2008 | WO2008061109A2 Indazole derivatives useful as melanin concentrating receptor ligands |
| 05/22/2008 | WO2008060481A1 Method for treating chronic pain |
| 05/22/2008 | WO2008060448A2 Small molecule pak inhibitors |
| 05/22/2008 | WO2008060375A2 Upregulating bdnf levels to mitigate mental retardation |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060228A1 Extended release formulations comprising quetipine and methods for their manufacture |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008059991A1 Diagnosis and treatment of autism using cd38 |
| 05/22/2008 | WO2008059965A1 Agent for alleviating or preventing stress symptoms and agent for improving mental conditions |
| 05/22/2008 | WO2008059959A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | WO2008059949A1 Knockout animal exhibiting anxiety-like behavior |
| 05/22/2008 | WO2008059870A1 Heat shock protein inducer, skin preparation for external use, food and drug containing the same, and method of producing heat shock protein inducer |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059800A1 Novel polyamine derivatives |
| 05/22/2008 | WO2008059267A1 Selective glycosidase inhibitors |
| 05/22/2008 | WO2008059224A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing |
| 05/22/2008 | WO2008059126A1 Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent |
| 05/22/2008 | WO2008058992A1 New crystalline form of entacapone and process for its preparation |
| 05/22/2008 | WO2008058988A1 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 05/22/2008 | WO2008058694A1 Extraction method for the classified extraction and separation of vegetable component materials, and the application thereof |
| 05/22/2008 | WO2008058537A1 Novel 2-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008058402A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | WO2008039898A3 Methods for the treatment of a traumatic central nervous system injury |
| 05/22/2008 | WO2008035001A3 Composition for the treatment of amyotrophic lateral sclerosis |
| 05/22/2008 | WO2008032191A3 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/22/2008 | WO2008022024A3 Imidazole amines as inhibitors of beta-secretase |
| 05/22/2008 | WO2008015023A3 Use of photomedin products for preventing and/or treating neuronal dysfunctions |
| 05/22/2008 | WO2008012413A3 Pyrimidinone derivatives and their use as a drug |
| 05/22/2008 | WO2007147770A3 Substituted phenyl methanone derivatives |
| 05/22/2008 | WO2007144169A3 Entacapone-derivatives |
| 05/22/2008 | WO2007130824A3 Fused heterocylic compounds and their use as mglur5 modulators |
| 05/22/2008 | US20080119566 Sedatives; oxidation resistance; nervous system disorders |
| 05/22/2008 | US20080119547 Treating of a psychological disorder by administering a 3-Benzo[1,3]dioxol-5-yl-indan-1-yl)-dimethylamine or analogous 1,3-dithio, 1-oxa-3-thio ring derivatives; antidepressants; anxiolytic agents; post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, phobias |
| 05/22/2008 | US20080119535 Aminomethyl-4-imidazoles |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119517 Compositions and methods for protecting against mitochondria component-mediated pathology |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
| 05/22/2008 | US20080119501 Immediate release oxymorphone compositions and methods of using same |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119489 Imidazole derivatives |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/22/2008 | US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/22/2008 | US20080119481 CNS disorders; sexual disorders; 5-HT1A binding agent |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119469 Novel Compounds |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119460 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 05/22/2008 | US20080119452 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H, 1-benzopyran-2,4'-piperidine]; non-peptidic delta opioid receptor synergistic withother active ingredients; antidepressant, anxiolytic agent; Alzheimer's Disease, age-related cognitive decline, Parkinson's Disease, AIDS, schizophrenia |